
Dermatology Primary and Secondary Lesions
Dermatology uses precise terminology to describe the appearance, timing, and pathogenesis of skin changes. Mastering the distinction between primary and secondary lesions is essential for…

How is a secondary skin lesion characterized?
Which description matches a scabies burrow (rãnh ghẻ)?
What does a positive Nikolsky sign indicate?
Which category includes lesions located beneath the skin surface?
What is the approximate global prevalence of psoriasis?
In the WHO classification, which group is considered paucibacillary (PB) leprosy?
Which skin manifestation is characteristic of a fixed drug eruption?
Which of the following is a typical primary lesion found on the skin surface?
What is the main public health measure recommended to prevent the spread of scabies?
Understanding Primary and Secondary Skin Lesions
Dermatology uses precise terminology to describe the appearance, timing, and pathogenesis of skin changes. Mastering the distinction between primary and secondary lesions is essential for accurate diagnosis, treatment planning, and communication among healthcare professionals.
What Is a Primary Skin Lesion?
A primary lesion is the initial skin change that appears at the onset of a disease process. It arises directly from the underlying pathology and is not the result of external manipulation such as scratching, infection, or trauma. Recognizing primary lesions helps clinicians identify the disease’s early stage and often points toward the specific etiologic category (e.g., inflammatory, infectious, neoplastic).
- Examples include macules, papules, vesicles, pustules, and plaques that develop before any secondary modifications.
- Primary lesions are typically symmetrical when the disease is systemic and may follow characteristic distribution patterns (e.g., the “butterfly” rash of lupus).
How Are Secondary Skin Lesions Characterized?
Secondary lesions develop after the primary lesion, often as a consequence of patient‑driven factors such as scratching, rubbing, or secondary infection. They reflect the skin’s response to the primary insult and can provide clues about disease activity, chronicity, and patient behavior.
- Common secondary changes include excoriations, crusts, scales, erosions, fissures, and ulcerations.
- These lesions may be asymmetrical and localized to areas of trauma, indicating the role of external forces.
- Identifying secondary lesions is crucial for managing complications, such as preventing infection in excoriated areas.
Key Dermatologic Signs and Their Clinical Relevance
Scabies Burrow (Rãnh Ghẻ)
Scabies is caused by the mite Sarcoptes scabiei. The classic manifestation is a burrow, which appears as a narrow, gray‑white tunnel within the epidermis, typically 1–15 mm long and slightly raised. These burrows are most often found in the web spaces of the fingers, wrists, elbows, and genital area.
- Burrows are primary lesions created by the mite’s movement and egg‑laying.
- Secondary lesions such as excoriations and papules may develop from scratching.
Positive Nikolsky Sign
The Nikolsky sign is elicited by applying gentle lateral pressure to the skin. A positive sign indicates that the epidermis separates from the dermis, suggesting an underlying blistering disorder such as pemphigus vulgaris or toxic epidermal necrolysis. This sign is a valuable diagnostic tool for differentiating intra‑epidermal from subepidermal blistering diseases.
- It reflects a loss of cohesion between keratinocytes, often due to auto‑antibody mediated damage.
- Recognition of a positive Nikolsky sign prompts urgent investigation and management.
Lesions Beneath the Skin Surface
Some dermatologic conditions produce lesions that lie deeper than the epidermis, involving the dermis, subcutaneous tissue, or even deeper structures. These are categorized as sub‑surface lesions and include atrophy, fibrosis, and ulceration.
- Atrophic lesions may result from chronic corticosteroid use or connective tissue diseases.
- Fibrotic changes are seen in conditions like scleroderma or post‑inflammatory scarring.
- Ulcerations indicate loss of the full thickness of the skin and often require specialized wound care.
Epidemiology and Classification of Common Dermatologic Diseases
Psoriasis Prevalence
Psoriasis affects approximately 1–3 % of the global population. It is a chronic immune‑mediated disease characterized by well‑demarcated, erythematous plaques with silvery scales. Understanding its prevalence underscores the public health impact and the need for effective therapeutic strategies.
Leprosy (Hansen’s Disease) Classification
The World Health Organization (WHO) classifies leprosy based on the number of skin lesions and bacillary load. Paucibacillary (PB) leprosy includes patients with no detectable bacilli or 1–5 skin lesions. In contrast, multibacillary (MB) leprosy involves more than five lesions and a positive bacillary index.
- Accurate classification guides the duration and type of multidrug therapy (MDT).
- Early detection of PB leprosy can prevent nerve damage and disability.
Fixed Drug Eruption (FDE)
A fixed drug eruption presents as a well‑defined, round or oval erythematous patch that recurs at the same site each time the offending drug is taken. The lesion may become hyperpigmented after resolution.
- FDE is a type of delayed hypersensitivity reaction (type IV) to medications such as antibiotics, NSAIDs, or anticonvulsants.
- Recognition of the characteristic pattern helps clinicians discontinue the culprit drug and prevent recurrence.
Integrating Knowledge into Clinical Practice
Effective dermatologic assessment requires a systematic approach:
- Identify primary lesions – note morphology, size, color, and distribution.
- Assess for secondary changes – look for excoriations, crusts, or infection that may modify the primary appearance.
- Apply specific signs (e.g., Nikolsky) to narrow differential diagnoses.
- Consider epidemiologic data (e.g., psoriasis prevalence) to gauge disease burden.
- Use classification systems (e.g., WHO leprosy categories) to determine treatment pathways.
By mastering these concepts, healthcare providers can improve diagnostic accuracy, tailor management plans, and ultimately enhance patient outcomes in dermatology.
